Between 50 and 65% of babies born with Down syndrome also have a congenital heart defect. That’s roughly a thousand times higher than the general population rate for certain types. The connection isn’t coincidental. It traces directly to the extra copy of chromosome 21 that defines Down syndrome, which disrupts the precise choreography of heart development during the first weeks of pregnancy.
How an Extra Chromosome Disrupts Heart Formation
Down syndrome occurs when a person has three copies of chromosome 21 instead of the usual two. This extra chromosome doesn’t just sit there quietly. Every gene on it produces roughly 50% more protein than normal, a phenomenon called gene dosage imbalance. During fetal development, heart cells are exquisitely sensitive to the amount of certain proteins. Even a modest overproduction at the wrong moment can throw off the signals that tell cells where to move, when to divide, and how to connect.
The heart forms remarkably early. By just 8 weeks of gestation, a simple tube has looped, divided into four chambers, and begun developing the walls (septa) and valves that separate those chambers. This process depends on structures called endocardial cushions, which are thick pads of tissue in the center of the developing heart. These cushions eventually fuse together to form the walls between the upper and lower chambers and the valves that control blood flow between them. In Down syndrome, the extra chromosome interferes with this fusion process, often leaving gaps in the walls or malformed valves.
The Key Genes Involved
Chromosome 21 carries several genes that are active during heart development, and researchers have identified a handful that play outsized roles when overexpressed.
One of the most significant is a gene that produces a kinase enzyme called DYRK1A. In mouse models of Down syndrome, having three copies of this gene instead of two reduces the ability of heart muscle cells to proliferate normally and impairs their mitochondria, the energy-producing structures inside cells. When researchers corrected the copy number back to two in these mice, heart wall defects were rescued. This suggests that the extra DYRK1A activity is not just associated with heart defects but is necessary to cause them. The enzyme appears to particularly affect the structures involved in building the walls between chambers, which explains why septal defects are so common.
Another important player is a gene called HMGN1, which helps regulate how DNA is packaged and read inside cells. A 2025 study published in Nature found that overexpression of HMGN1 shifts heart cells in the critical junction area between the atria and ventricles toward behaving like ventricular cells instead of maintaining their specialized identity. When the researchers deleted one copy of HMGN1 in cells with trisomy 21, normal gene expression patterns were restored.
Two other chromosome 21 genes, DSCAM and COL6A2, work together in a way that illustrates how the dosage problem can be surprisingly specific. DSCAM is an adhesion molecule on cell surfaces, and COL6A2 helps build the scaffolding between cells. Overexpressing either one alone doesn’t cause heart defects in mice. But overexpressing both simultaneously, as trisomy 21 does, dramatically increases how strongly cells stick to each other and to their surrounding scaffold. This excess stickiness disrupts the delicate remodeling that endocardial cushions must undergo to properly fuse into septa and valves.
Why Septal Defects Are the Most Common Type
Not all heart defects occur equally in Down syndrome. The breakdown looks roughly like this: about 45% are atrioventricular septal defects (gaps in the center of the heart where both the upper and lower chamber walls meet the valves), 35% are ventricular septal defects (holes in the wall between the lower chambers), 8% are atrial septal defects (holes in the wall between the upper chambers), 7% are patent ductus arteriosus (a fetal blood vessel that fails to close after birth), and 4% are tetralogy of Fallot (a combination of four structural problems).
The dominance of atrioventricular septal defects is striking. In a Norwegian study tracking all births over several decades, 44.4% of heart defects in babies with Down syndrome were this type. In the general population, atrioventricular septal defects are quite rare. The reason for this concentration goes back to those endocardial cushions. The center of the heart, where the atria meet the ventricles, is the last and most complex area to fully partition. It requires cushion tissue to fuse with the bottom edge of the atrial wall and the top of the ventricular wall simultaneously. The overproduction of adhesion molecules and structural proteins from the extra chromosome appears to interfere most at this precise junction point. A structure called the dorsal mesenchymal protrusion, which helps complete the separation of the chambers, also develops abnormally when signaling pathways are disrupted by the extra chromosome.
Detection Before and After Birth
Fetal echocardiography can identify cardiac structures as early as 10 to 12 weeks using specialized probes, though the optimal window for a screening exam is 20 to 22 weeks of pregnancy, when the heart is large enough to visualize clearly in over 90% of cases. The standard screening view, a four-chamber image of the fetal heart, can detect between 43% and 96% of anomalies depending on the skill of the sonographer and the specific defect. Adding views of the outflow tracts (the vessels leaving the heart) improves detection, though these are harder to assess.
Because heart defects are so common in Down syndrome, babies with the diagnosis typically receive an echocardiogram shortly after birth even if prenatal imaging looked normal. Some defects, particularly small holes in the ventricular wall, can be difficult to spot before delivery.
Surgical Repair and Survival
The outlook for children with Down syndrome and heart defects has improved dramatically over the past four decades. Five-year survival for those born with heart defects rose from 85% in the 1980s to 93% for those born between 2010 and 2018. For children born in that most recent period, there was no significant difference in five-year survival between those with heart defects and those without. Multiple studies have found that survival after cardiac surgery in children with Down syndrome is comparable to, or even slightly better than, survival in children without Down syndrome who undergo the same procedures.
The type of defect matters, though. Children with simple atrial septal defects have survival rates essentially identical to children with no heart defect at all. Ventricular septal defects carry slightly lower survival. Atrioventricular septal defects, the most common type, carry the greatest long-term risk, particularly after the five-year mark. This likely reflects the complexity of the repair and the potential for valve problems to develop over time. Still, the overall trend is strongly positive, with survival gaps narrowing steadily with each passing decade as surgical techniques and postoperative care have advanced.